{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:36:11Z","timestamp":1761766571058,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijantimicag.2019.08.011","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:46:43Z","timestamp":1565178403000},"page":"423-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Daptomycin-containing regimens for treatment of Gram-positive endocarditis"],"prefix":"10.1016","volume":"54","author":[{"given":"Alessandro","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Givone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ingani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijantimicag.2019.08.011_bib0001","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s15010-012-0285-y","article-title":"Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian study on endocarditis","volume":"40","author":"Leone","year":"2012","journal-title":"Infection"},{"year":"2018","series-title":"Surveillance of antimicrobial resistance in Europe \u2013 Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","key":"10.1016\/j.ijantimicag.2019.08.011_bib0003"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.08.011_bib0004","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/13543784.8.8.1223","article-title":"Daptomycin: a novel agent for Gram-positive infections","volume":"8","author":"Tally","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2334-7-29","article-title":"Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005)","volume":"7","author":"Sader","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0006","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2013.05.005","article-title":"Daptomycin: the role of high-dose and combination therapy for Gram-positive infections","volume":"42","author":"Gould","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0007","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.ijantimicag.2019.08.011_bib0008","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"10.1016\/j.ijantimicag.2019.08.011_bib0009","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0010","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/cid\/cit112","article-title":"Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg\/L: a matched cohort study","volume":"56","author":"Murray","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0011","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/jac\/dkt294","article-title":"A multicentre evaluation of the effectiveness and safety of high dose daptomycin for the treatment of infective endocarditis","volume":"68","author":"Kullar","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0012","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modification to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0013","unstructured":"http:\/\/www.euroscore.org\/calc.html[accessed 30 January 2019]."},{"issue":"9","key":"10.1016\/j.ijantimicag.2019.08.011_bib0014","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0195-668X(02)00799-6","article-title":"The logistic EuroSCORE","volume":"24","author":"Roques","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.08.011_bib0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0016","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0017","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13019-016-0519-7","article-title":"Daptomycin for the treatment of major Gram-positive infections after cardiac surgery","volume":"11","author":"Kornberger","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0018","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/AAC.01921-12","article-title":"Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group streptococci after exposure to daptomycin","volume":"57","author":"Garc\u00eda-de-la-M\u00e0ria","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0019","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/AAC.04219-14","article-title":"Characterization of high-level daptomycin resistance in viridans group streptococci developed upon in vitro exposure to daptomycin","volume":"59","author":"Akins","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.08.011_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The Nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0021","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijcard.2014.09.184","article-title":"Infective endocarditis in elderly: an Italian prospective multi-center observational study","volume":"177","author":"Bassetti","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ijantimicag.2019.08.011_bib0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijantimicag.2010.07.011","article-title":"High-dose daptomycin in documented Staphylococcus aureus infections","volume":"36","author":"Bassetti","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0023","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s00134-015-4021-9","article-title":"Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jac\/dkm170","article-title":"Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation using historical and current dosing strategies","volume":"60","author":"Rose","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0025","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.06439-11","article-title":"Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1592\/phco.24.1.41.34802","article-title":"Daptomycin","volume":"24","author":"Tedesco","year":"2004","journal-title":"Pharmacother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0027","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2009.04.001","article-title":"Long course of daptomycin in the treatment of methicillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitis","volume":"34","author":"Bassetti","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.ijantimicag.2019.08.011_bib0028","first-page":"41","article-title":"Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data","volume":"4","author":"Guleri","year":"2017","journal-title":"Ther Adv Infect Dis"},{"issue":"7-8","key":"10.1016\/j.ijantimicag.2019.08.011_bib0029","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1345\/aph.1P745","article-title":"TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient","volume":"45","author":"Pea","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2019.08.011_bib0030","first-page":"117","article-title":"Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment","volume":"74","author":"Gr\u00e9goire","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.08.011_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170236","article-title":"Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality","volume":"12","author":"Bassetti","year":"2017","journal-title":"PLoS One"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919302225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:42Z","timestamp":1760376762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919302225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0924857919302225"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daptomycin-containing regimens for treatment of Gram-positive endocarditis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}